Shanghai Haohai Biological Technology Co., Ltd (6826.HK) reported earnings for full year that Dropped, from the same period last year
The company's bottom line came in at RMB251.01 million, or RMB1.08 per share. This compares with RMB420.45 million, or RMB1.80 per share, last year.
The company's revenue for the period fell 8.7% to RMB2.446 billion from RMB2.679 billion last year.
Shanghai Haohai Biological Technology Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB251.01 Mln. vs. RMB420.45 Mln. last year.-EPS: RMB1.08 vs. RMB1.80 last year.-Revenue: RMB2.446 Bln vs. RMB2.679 Bln last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.